MESA LABS DECLARES QUARTERLY DIVIDEND
July 06 2020 - 12:00PM
- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs”
or the “Company”) today announced that its Board of Directors has
declared a regular quarterly dividend of $0.16 per share of common
stock. The dividend will be payable on September 15, 2020, to
shareholders of record at the close of business on August 31, 2020.
About Mesa Laboratories, Inc.Mesa Labs is a global technology
innovator committed to solving some of the most critical quality
control challenges in the pharmaceutical, healthcare, industrial
safety, environmental and food and beverage industries. Mesa
Labs offers products and services through four divisions
(Sterilization and Disinfection Control, Biopharmaceutical
Development, Instruments and Continuous Monitoring) to help our
customers ensure product integrity, increase patient and worker
safety, and improve the quality of life throughout the world.
Forward Looking StatementsThis press release may contain
information that constitutes forward-looking statements.
Forward-looking statements are subject to risks and
uncertainties that could cause actual results to differ materially
from our historical experience and present expectations or
projections. Forward-looking statements include statements
relating to revenues and growth, operating results, profit margin
pressure, industry conditions, economic conditions, demand,
competition, the effects of additional actions taken to become more
efficient or lower costs, risks related to the integration of
acquired businesses, changes in legal and regulatory matters, the
ability to generate additional cash flow, and the duration and
impact of the COVID-19 pandemic and the myriad of its effects on
our business including related decreases in customer demand and
spending, and any events or developments that we expect or
anticipate will occur in the future. Generally, the
words “expect,” “seek,” “anticipate,” “intend,” “plan,” “believe,”
“could,” “estimate,” “may,” “target,” “project,” and similar
expressions identify forward-looking statements. However, the
absence of these words or similar expressions does not mean that a
statement is not forward-looking. These statements are based
upon current information and expectations. Actual results may
differ materially from those estimated or anticipated as a result
of these risks and unknowns or other risks and uncertainties.
For additional information concerning these and other risks and
uncertainties that could affect these statements, and the our
business, see our Annual Report on Form 10-K for the year ended
March 31, 2020, as well as other risks and uncertainties detailed
from time to time in our reports on Forms 10-Q and 8-K subsequently
filed with the Securities and Exchange Commission. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. We
undertake no obligation to republish revised forward-looking
statements to reflect events or circumstances after the date
hereof, to provide any updates, or to reflect the occurrence of
future events.
For more information about the Company, please visit its website
at www.mesalabs.com
CONTACT: Gary Owens; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Apr 2023 to Apr 2024